US Leveraged Loan Market Under Strain as More Deals Are Pulled


The US leveraged loan market is coming under further pressure with its second pulled deal in a week and a slew of investor-friendly changes made on other transactions to help get them over the line.

The latest casualty is drugmaker Mallinckrodt, which shelved a $1.49 billion offering on Friday, according to people with knowledge of the matter, who asked not to be identified discussing a private matter.

It follows a pulled deal from specialty chemicals producer Nouryon earlier this week, marking the eighth deal to be yanked from the market since August, according to data compiled by Bloomberg.

Representatives for Mallinckrodt and Goldman Sachs Group Inc., which is managing the sale, didn’t immediately provide a comment.

Marketing for Mallinckrodt’s loan, a so-called repricing which would have cut the borrowing rate on the debt by as much as 0.75 percentage point, began on Monday. Investors had until Thursday to put in their orders.

Demand for risky debt has softened in the past few weeks for a number of reasons. Primarily, debt offerings tied to acquisitions and buyouts have picked up, giving investors an opportunity to get better returns than those offered on repricings.

Some investors have also been spooked by the bankruptcy of auto-parts supplier First Brands, which filed after failing to complete a $6 billion refinancing. And concerns about higher costs in the chemical sector impacted demand for Nouryon’s offering.

Secondary-market prices, meanwhile, have fallen almost every day for the last two weeks, a Bloomberg index shows.

Elsewhere, banks wrapped up a leveraged loan sale to help fund an acquisition by MJH Life Sciences, but had to offer one of the steepest discounts of the year as investors become pickier about some risky debt deals.

A group of banks led by Banco Santander SA, meanwhile, will be forced to keep a portion of a $2.7 billion financing to support an acquisition. Commitments for the loan sale are due Tuesday.

This article was generated from an automated news agency feed without modifications to text.


Related Posts

In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

Amid rising geopolitical tensions and volatile global cues, Indian equity markets are witnessing a sharp reality check, reshaping investor sentiment and valuation dynamics. The recent correction, particularly in mid- and…

Stocks to buy under ₹100: Sumeet Bagadia recommends three stocks to buy on Monday – 23 March 2026

Indian stock market: The Indian stock market closed the week largely on a flat note with a slight negative bias, indicating underlying caution among participants. Sentiment remained positive in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cristiano Ronaldo’s 1000-goal chase is not an obsession, insists Portugal boss Roberto Martinez ahead of FIFA World Cup| Football News

  • By admin
  • March 22, 2026
  • 1 views
Cristiano Ronaldo’s 1000-goal chase is not an obsession, insists Portugal boss Roberto Martinez ahead of FIFA World Cup| Football News

Inside the 20,000-sq-ft Amritsar mansion that doubles as Ranveer Singh aka Hamza’s palatial bungalow in Dhurandhar 2 | Bollywood News

  • By admin
  • March 22, 2026
  • 2 views
Inside the 20,000-sq-ft Amritsar mansion that doubles as Ranveer Singh aka Hamza’s palatial bungalow in Dhurandhar 2 | Bollywood News

In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

  • By admin
  • March 22, 2026
  • 1 views
In a best-case scenario, the ongoing chaos can bring opportunity in next month, says expert

What is Claude Code Channels, Anthropic’s take on OpenClaw-style AI agent setups? | Technology News

  • By admin
  • March 22, 2026
  • 1 views
What is Claude Code Channels, Anthropic’s take on OpenClaw-style AI agent setups? | Technology News

Mohsin Naqvi threatens legal action against international players choosing IPL 2026 over PSL: ‘2-3 have left’

  • By admin
  • March 22, 2026
  • 2 views
Mohsin Naqvi threatens legal action against international players choosing IPL 2026 over PSL: ‘2-3 have left’

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

  • By admin
  • March 22, 2026
  • 1 views
Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots